4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-016065
Chief Medical Officer gave up 5,512 shares (to pay taxes)
- Chief Medical Officer acquired 20,600 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gordon David N. Chief Medical Officer | 2020-03-02 | Option exercise | +20,600 | 24,952 | D | ||
| Gordon David N. Chief Medical Officer | 2020-03-02 | Shares withheld for taxes | −5,512 | $1.26 | $6,945 | 19,440 | D |
| Derivatives | |||||||
| Gordon David N. Chief Medical Officer | 2020-03-02 | Option exercise · Restricted stock units | −20,600 | 61,800 | D | ||
| Gordon David N. Chief Medical Officer | 2020-03-02 | Grant or award · Employee Stock Option (Right to Buy) | +116,160 | 116,160 | D | ||
| Gordon David N. Chief Medical Officer | 2020-03-02 | Grant or award · Restricted stock units | +33,189 | 33,189 | D | ||
Loading xslF345X03/doc4.xml…